Wall Street analysts predict that Uxin Ltd (NASDAQ:UXIN) will report ($0.09) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Uxin’s earnings. Uxin reported earnings per share of ($0.03) in the same quarter last year, which would indicate a negative year-over-year growth rate of 200%. The company is expected to report its next quarterly earnings results on Wednesday, August 28th.

According to Zacks, analysts expect that Uxin will report full year earnings of ($0.24) per share for the current fiscal year, with EPS estimates ranging from ($0.29) to ($0.19). For the next financial year, analysts anticipate that the firm will post earnings of $0.45 per share, with EPS estimates ranging from $0.42 to $0.48. Zacks’ EPS averages are a mean average based on a survey of research firms that cover Uxin.

Uxin (NASDAQ:UXIN) last announced its earnings results on Monday, June 10th. The company reported ($0.78) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.59). The business had revenue of $1 billion for the quarter. Uxin had a negative net margin of 26.17% and a negative return on equity of 97.42%. Uxin’s revenue for the quarter was up 54.6% compared to the same quarter last year.

UXIN has been the topic of several analyst reports. Zacks Investment Research downgraded shares of G1 Therapeutics from a “buy” rating to a “hold” rating in a report on Thursday, May 16th. ValuEngine downgraded shares of Intersect ENT from a “buy” rating to a “hold” rating in a report on Monday, June 3rd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Uxin currently has a consensus rating of “Buy” and a consensus target price of $7.50.

NASDAQ UXIN traded down $0.10 during trading hours on Monday, hitting $2.59. 4,322,408 shares of the company’s stock traded hands, compared to its average volume of 5,350,726. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.44 and a quick ratio of 1.43. Uxin has a 52 week low of $1.41 and a 52 week high of $9.87. The firm has a market capitalization of $786.54 million and a price-to-earnings ratio of -0.75. The stock has a fifty day simple moving average of $2.19.

A number of large investors have recently modified their holdings of the business. BlackRock Inc. lifted its stake in Uxin by 78.4% in the 4th quarter. BlackRock Inc. now owns 129,527 shares of the company’s stock valued at $630,000 after purchasing an additional 56,926 shares during the last quarter. Blueshift Asset Management LLC acquired a new stake in Uxin during the fourth quarter worth approximately $87,000. Hsbc Holdings PLC acquired a new stake in Uxin during the fourth quarter worth approximately $68,000. Baillie Gifford & Co. lifted its position in Uxin by 402.6% during the fourth quarter. Baillie Gifford & Co. now owns 1,248,400 shares of the company’s stock worth $6,067,000 after acquiring an additional 1,000,000 shares during the last quarter. Finally, Two Sigma Investments LP acquired a new stake in Uxin during the fourth quarter worth approximately $72,000. 32.12% of the stock is currently owned by institutional investors and hedge funds.

About Uxin

Uxin Limited, through its subsidiaries, operates an used car e-commerce platform in China. It operates Uxin Used Car, an application that provides consumers with customized car recommendation, financing, title transfer, delivery, insurance referral, warranty and other related services; and Uxin Auction, an application that helps business buyers to source vehicles through online auctions.

Read More: What is the strike price in options trading?

Get a free copy of the Zacks research report on Uxin (UXIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Uxin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uxin and related companies with MarketBeat.com's FREE daily email newsletter.